Status:
COMPLETED
Does the Merged 3D Imaging Improve Contact Force and Long Term Procedure Outcome in Atrial Fibrillation?
Lead Sponsor:
Korea University Guro Hospital
Collaborating Sponsors:
Johnson & Johnson
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The purpose of the study is to investigate whether or not there are the differences in acute procedure and long-term clinical outcome of radiofrequency catheter ablation (RFCA) for atrial fibrillation...
Detailed Description
In a recent study, ablation therapy of AF was superior to antiarrhythmic drug therapy alone in preventing atrial arrhythmia recurrences in patients with paroxysmal or persistent AF. Various techniques...
Eligibility Criteria
Inclusion
- Patients undergoing first-time catheter ablation for AF.
- Willing and able to provide informed consent
- Age greater than or equal to 18 years.
Exclusion
- Patients who have previously undergone AF ablation
- Patients with more than mild mitral valve stenosis or mechanical mitral valve replacement
- Patients with chronic renal impairment with creatinine clearance rate of \< 50
Key Trial Info
Start Date :
November 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03350581
Start Date
November 21 2017
End Date
November 30 2019
Last Update
December 3 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Guro Hospital
Seoul, Guro-gu, South Korea, 08308
2
Bucheon Sejong Hospital
Bucheon-si, South Korea, 14754